Results 41 to 50 of about 193,736 (306)

Physicians Infrequently Adhere to Hepatitis Vaccination Guidelines for Chronic Liver Disease [PDF]

open access: yes, 2013
Background and Goals:Hepatitis A (HAV) and hepatitis B (HBV) vaccination in patients with chronic liver disease is an accepted standard of care. We determined HAV and HBV vaccination rates in a tertiary care referral hepatology clinic and the impact of ...
Dhiraj Yadav   +15 more
core   +1 more source

Detection of hepatitis A, B, and C virus-specific antibodies using oral fluid for epidemiological studies

open access: yesMemorias do Instituto Oswaldo Cruz, 2006
In this report, we examine the adaptability of commercially available serological kits to detect antibodies markers for viral hepatitis in oral fluid samples. We also assessed the prevalence of hepatitis A, B, and C virus-specific antibodies, and related
Luciane A Amado   +4 more
doaj   +1 more source

Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors

open access: yes, 2010
Hepatitis C virus (HCV) naturally infects only humans and chimpanzees. The determinants responsible for this narrow species tropism are not well defined.
Christiane Brohm   +25 more
core   +1 more source

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

open access: yesMolecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner   +14 more
wiley   +1 more source

Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine

open access: yesHuman Vaccines & Immunotherapeutics, 2017
Vaccination is the most effective and well-tolerated method of conferring long-term protection against hepatitis A and B viruses (HAV; HBV). Long-term studies are required to characterize the duration of protection and need for boosters.
Pierre Van Damme   +4 more
doaj   +1 more source

Correlation analysis of Th1/Th2 cytokines and liver fibrosis indicators in chronic hepatitis B patients [PDF]

open access: yesJournal of Medical Biochemistry
Background: To investigate the potential therapeutic benefits of autoimmune antibody detection in individuals suffering from chronic hepatitis B. Methods: In the observation group, 102 patients with chronic hepatitis B who were admitted between March ...
Yu Chun   +5 more
doaj   +1 more source

Hepatitis B virus antibody prevalence in anaesthetists [PDF]

open access: yesCanadian Anaesthetists’ Society Journal, 1984
The prevalence of antibodies to hepatitis B virus (anti HBs or anti HBc) was 16.9 per cent in a group of anaesthetists, compared to 3.7 per cent in volunteer blood donors and 5.6 per cent of patients without hepatic infections. Professional risk factors such as treating a hepatitis B patient or working in a hospital laboratory, haemodialysis, an ...
M A, Chernesky, R A, Browne, P, Rondi
openaire   +2 more sources

Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas [PDF]

open access: yes, 1996
This paper uses meta-analysis of published data and a deterministic mathematical model of hepatitis B virus (HBV) transmission to describe the patterns of HBV infection in high endemicity areas.
Edmunds, W. John   +5 more
core   +1 more source

Pharmacological inhibition of the PERK pathway modulates hepatocellular carcinoma growth and immune signaling

open access: yesFEBS Open Bio, EarlyView.
Pharmacological inhibition of PERK in a DEN‐induced mouse model of liver cancer does not reduce tumor burden but alters cellular stress signaling. Despite blocking PERK activity, downstream stress responses, including CHOP expression, remain active, suggesting compensatory mechanisms within the unfolded protein response that may influence tumor ...
Ada Lerma‐Clavero   +5 more
wiley   +1 more source

Hepatitis B Vaccination in Persons with Isolated Hepatitis B Core Antibodies [PDF]

open access: yesClinical Infectious Diseases, 1999
SIR-Silva et al. [1] suggested that in the population they have studied, isolated antibodies to hepatitis B core antigen (anti-HBc) are false-positive results. Their arguments are based on the facts that only five persons among the 133 investigated had hepatitis B virus (HBV) DNA detected in their serum and that most had a primary response to HBV ...
Brian J. McMahon, Alan J. Parkinson
openaire   +3 more sources

Home - About - Disclaimer - Privacy